Plumb J - Search Results

1

In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance.

Mistry P, Plumb J, Eccles S, Watson S, Dale I, Ryder H, Box G, Charlton P, Templeton D, Bevan PB. Mistry P, et al. Among authors: plumb j. Br J Cancer. 1999 Apr;79(11-12):1672-8. doi: 10.1038/sj.bjc.6690267. Br J Cancer. 1999. PMID: 10206276 Free PMC article.

2

In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.

Mistry P, Stewart AJ, Dangerfield W, Okiji S, Liddle C, Bootle D, Plumb JA, Templeton D, Charlton P. Mistry P, et al. Among authors: plumb ja. Cancer Res. 2001 Jan 15;61(2):749-58. Cancer Res. 2001. PMID: 11212278

3

P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies.

Wishart GC, Plumb JA, Going JJ, McNicol AM, McArdle CS, Tsuruo T, Kaye SB. Wishart GC, et al. Among authors: plumb ja. Br J Cancer. 1990 Nov;62(5):758-61. doi: 10.1038/bjc.1990.373. Br J Cancer. 1990. PMID: 1978783 Free PMC article.

4

Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo.

Steele N, Finn P, Brown R, Plumb JA. Steele N, et al. Among authors: plumb ja. Br J Cancer. 2009 Mar 10;100(5):758-63. doi: 10.1038/sj.bjc.6604932. Br J Cancer. 2009. PMID: 19259094 Free PMC article.

5

Effect of polyunsaturated fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicin.

Plumb JA, Luo W, Kerr DJ. Plumb JA, et al. Br J Cancer. 1993 Apr;67(4):728-33. doi: 10.1038/bjc.1993.133. Br J Cancer. 1993. PMID: 8385976 Free PMC article.

6

Characterisation and properties of a small cell lung cancer cell line and xenograft WX322 with marked sensitivity to alpha-interferon.

Langdon SP, Rabiasz GJ, Anderson L, Ritchie AA, Fergusson RJ, Hay FG, Miller EP, Mullen P, Plumb J, Miller WR, et al. Langdon SP, et al. Among authors: plumb j. Br J Cancer. 1991 Jun;63(6):909-15. doi: 10.1038/bjc.1991.200. Br J Cancer. 1991. PMID: 1712622 Free PMC article.

7

DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.

Plumb JA, Gerritsen M, Workman P. Plumb JA, et al. Br J Cancer. 1994 Dec;70(6):1136-43. doi: 10.1038/bjc.1994.461. Br J Cancer. 1994. PMID: 7526885 Free PMC article.

8

Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101.

Plumb JA, Finn PW, Williams RJ, Bandara MJ, Romero MR, Watkins CJ, La Thangue NB, Brown R. Plumb JA, et al. Mol Cancer Ther. 2003 Aug;2(8):721-8. Mol Cancer Ther. 2003. PMID: 12939461

9

Adequate tumour quinidine levels for multidrug resistance modulation can be achieved in vivo.

Wishart GC, Plumb JA, Morrison JG, Hamilton TG, Kaye SB. Wishart GC, et al. Among authors: plumb ja. Eur J Cancer. 1992;28(1):28-31. doi: 10.1016/0959-8049(92)90377-e. Eur J Cancer. 1992. PMID: 1567680

10

Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil.

Merry S, Fetherston CA, Kaye SB, Freshney RI, Plumb JA. Merry S, et al. Among authors: plumb ja. Br J Cancer. 1986 Jan;53(1):129-35. doi: 10.1038/bjc.1986.18. Br J Cancer. 1986. PMID: 3947509 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters